Baidu
map

颠覆!自闭症患者对癌症具有“免疫力”

2016-05-18 佚名 Happy猫(ID:happyhappy

《你是我的眼》这首歌相信很多人都不陌生,歌词“你是我的眼,带我领略四季的变换;你是我的眼,带我穿越拥挤的人潮;你是我的眼,带我阅读浩瀚的书海;因为你是我的眼,让我看见这世界就在我眼前…”感动了无数人。而现实生活还有这么些人,他们视力正常,可以看见光明,可是你却无法走进他们的世界。  自闭症(autism)又称孤独症、孤独性障碍(autistic disorder)等,是广泛性发

《你是我的眼》这首歌相信很多人都不陌生,歌词“你是我的眼,带我领略四季的变换;你是我的眼,带我穿越拥挤的人潮;你是我的眼,带我阅读浩瀚的书海;因为你是我的眼,让我看见这世界就在我眼前…”感动了无数人。而现实生活还有这么些人,他们视力正常,可以看见光明,可是你却无法走进他们的世界。


 

自闭症(autism)又称孤独症、孤独性障碍(autistic disorder)等,是广泛性发育障碍(pervasive developmental disorder,PDD)的代表性疾病。虽然自闭症的病因还不完全清楚,但目前的研究表明,某些危险因素可能同自闭症的发病相关。在美国,68个儿童中估计就有1个患有自闭症,其中大部分是男孩。自闭症患者有很多癌症突变基因,但是癌症发病率比正常人低。这项新的研究被美国爱荷华大学的研究人员所证明。
 
 

研究负责人 、爱荷华大学医学院的博士Benjamin Darbro 指出,关于自闭症和癌症之间的关系问题并不是首次提出;之前已经有研究证明这两者之间存在风险基因。“但是,我们已经证明这个在基因组层面的重叠比之前报道的更为广泛,并且这个研究在一定层面上可以帮助我们降低患癌风险。”该项研究结果发布在《Plos One 》上面。
 

研究发现,自闭症患者具有罕见的、编码变异特质——基因具有致癌的潜力——对于那些没有自闭症的人来说,不确定有肿瘤抑制基因。随后,该团队采取了一些措施以确保正常人的遗传结构差异低于自闭症患者。

研究人员发现,与对照组相比,自闭症患者的基因中存在更多的变异,以至于出现癫痫和智力障碍。当研究小组分析了自闭症组和对照组的基因在其他不相关的疾病——包括骨髓发育不良、色素视网膜炎、扩张性心肌病后发现,他们的DNA变异没有什么差异。 

 

14岁以下的自闭症儿童对癌症具有天然的抵抗力,跟没有自闭症的同龄孩子相比患癌风险低于94%。研究人员还发现自闭症跟高血压以及糖尿病之间的没有相关性;也没发现与癌症发病率相关的胃灼热、过敏、湿疹之间的关系。 这表明,自闭症患者对癌症的“免疫力”并不是因为什么“技术神器”的催化,而是因为自闭症患者自身的“基因结构”!这个结论进一步支持了自闭症与癌症之间共享遗传信息,并且很有可能某天治疗癌症的药物同样也能治愈自闭症。  

关于自闭症

1. 引起自闭症的危险因素可以归纳为:遗传、感染与免疫和孕期理化因子刺激。
2. 自闭症的患病率为儿童人口的2~5/万人;
3. 自闭症多见于男孩,男女比例约为3:1~4:1;
4. 女孩症状一般较男孩严重;
5. 交流障碍;
6. 重复刻板行为;
7. 智力异常;
8. 感觉异常等;
9. 预防是降低孤独症出生风险的重要措施。在女性怀孕早期,即胚胎神经管形成和发育期,应避免滥用药,特别是抗癫痫类药物;避免病毒性感染;避开冷热温差变化较大的环境;以及避免受重大精神刺激和创伤等。
10. 治疗:TEACCH法、 ABA法、RDI和地板时光、 感觉统合训练、药物治疗等。
 
愿自闭症者可以打开自己的心扉,迎接灿烂阳光。

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=138149, encodeId=037c13814994, content=拜读,好文, beContent=null, objectType=article, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzdAIB7UwTkHt6fQkBP8ictliaXtc5gCUmYdAW1sAETC2nhO3q6YjRHkUibyOCtP8ibmXNObTyd63A076/0, createdBy=d4111948983, createdName=1e10c84am36(暂无匿称), createdTime=Fri Sep 30 15:19:51 CST 2016, time=2016-09-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1307686, encodeId=71b6130e68617, content=<a href='/topic/show?id=85d2289e188' target=_blank style='color:#2F92EE;'>#免疫力#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=28971, encryptionId=85d2289e188, topicName=免疫力)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3547346, createdName=dongjia2010, createdTime=Fri May 20 00:50:00 CST 2016, time=2016-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1527609, encodeId=b1ef152e60914, content=<a href='/topic/show?id=68b5863e5d2' target=_blank style='color:#2F92EE;'>#自闭#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=86375, encryptionId=68b5863e5d2, topicName=自闭)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=159511872623, createdName=xiongke014, createdTime=Fri May 20 00:50:00 CST 2016, time=2016-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=86562, encodeId=ed5f865627b, content=一家之言, beContent=null, objectType=article, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7cde98330, createdName=milkshark, createdTime=Thu May 19 07:42:00 CST 2016, time=2016-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=86561, encodeId=7d4e865611f, content=这是真的?, beContent=null, objectType=article, channel=null, level=null, likeNumber=127, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7cde98330, createdName=milkshark, createdTime=Thu May 19 07:41:00 CST 2016, time=2016-05-19, status=1, ipAttribution=)]
    2016-09-30 1e10c84am36(暂无匿称)

    拜读,好文

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=138149, encodeId=037c13814994, content=拜读,好文, beContent=null, objectType=article, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzdAIB7UwTkHt6fQkBP8ictliaXtc5gCUmYdAW1sAETC2nhO3q6YjRHkUibyOCtP8ibmXNObTyd63A076/0, createdBy=d4111948983, createdName=1e10c84am36(暂无匿称), createdTime=Fri Sep 30 15:19:51 CST 2016, time=2016-09-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1307686, encodeId=71b6130e68617, content=<a href='/topic/show?id=85d2289e188' target=_blank style='color:#2F92EE;'>#免疫力#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=28971, encryptionId=85d2289e188, topicName=免疫力)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3547346, createdName=dongjia2010, createdTime=Fri May 20 00:50:00 CST 2016, time=2016-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1527609, encodeId=b1ef152e60914, content=<a href='/topic/show?id=68b5863e5d2' target=_blank style='color:#2F92EE;'>#自闭#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=86375, encryptionId=68b5863e5d2, topicName=自闭)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=159511872623, createdName=xiongke014, createdTime=Fri May 20 00:50:00 CST 2016, time=2016-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=86562, encodeId=ed5f865627b, content=一家之言, beContent=null, objectType=article, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7cde98330, createdName=milkshark, createdTime=Thu May 19 07:42:00 CST 2016, time=2016-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=86561, encodeId=7d4e865611f, content=这是真的?, beContent=null, objectType=article, channel=null, level=null, likeNumber=127, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7cde98330, createdName=milkshark, createdTime=Thu May 19 07:41:00 CST 2016, time=2016-05-19, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=138149, encodeId=037c13814994, content=拜读,好文, beContent=null, objectType=article, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzdAIB7UwTkHt6fQkBP8ictliaXtc5gCUmYdAW1sAETC2nhO3q6YjRHkUibyOCtP8ibmXNObTyd63A076/0, createdBy=d4111948983, createdName=1e10c84am36(暂无匿称), createdTime=Fri Sep 30 15:19:51 CST 2016, time=2016-09-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1307686, encodeId=71b6130e68617, content=<a href='/topic/show?id=85d2289e188' target=_blank style='color:#2F92EE;'>#免疫力#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=28971, encryptionId=85d2289e188, topicName=免疫力)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3547346, createdName=dongjia2010, createdTime=Fri May 20 00:50:00 CST 2016, time=2016-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1527609, encodeId=b1ef152e60914, content=<a href='/topic/show?id=68b5863e5d2' target=_blank style='color:#2F92EE;'>#自闭#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=86375, encryptionId=68b5863e5d2, topicName=自闭)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=159511872623, createdName=xiongke014, createdTime=Fri May 20 00:50:00 CST 2016, time=2016-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=86562, encodeId=ed5f865627b, content=一家之言, beContent=null, objectType=article, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7cde98330, createdName=milkshark, createdTime=Thu May 19 07:42:00 CST 2016, time=2016-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=86561, encodeId=7d4e865611f, content=这是真的?, beContent=null, objectType=article, channel=null, level=null, likeNumber=127, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7cde98330, createdName=milkshark, createdTime=Thu May 19 07:41:00 CST 2016, time=2016-05-19, status=1, ipAttribution=)]
    2016-05-20 xiongke014
  4. [GetPortalCommentsPageByObjectIdResponse(id=138149, encodeId=037c13814994, content=拜读,好文, beContent=null, objectType=article, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzdAIB7UwTkHt6fQkBP8ictliaXtc5gCUmYdAW1sAETC2nhO3q6YjRHkUibyOCtP8ibmXNObTyd63A076/0, createdBy=d4111948983, createdName=1e10c84am36(暂无匿称), createdTime=Fri Sep 30 15:19:51 CST 2016, time=2016-09-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1307686, encodeId=71b6130e68617, content=<a href='/topic/show?id=85d2289e188' target=_blank style='color:#2F92EE;'>#免疫力#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=28971, encryptionId=85d2289e188, topicName=免疫力)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3547346, createdName=dongjia2010, createdTime=Fri May 20 00:50:00 CST 2016, time=2016-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1527609, encodeId=b1ef152e60914, content=<a href='/topic/show?id=68b5863e5d2' target=_blank style='color:#2F92EE;'>#自闭#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=86375, encryptionId=68b5863e5d2, topicName=自闭)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=159511872623, createdName=xiongke014, createdTime=Fri May 20 00:50:00 CST 2016, time=2016-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=86562, encodeId=ed5f865627b, content=一家之言, beContent=null, objectType=article, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7cde98330, createdName=milkshark, createdTime=Thu May 19 07:42:00 CST 2016, time=2016-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=86561, encodeId=7d4e865611f, content=这是真的?, beContent=null, objectType=article, channel=null, level=null, likeNumber=127, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7cde98330, createdName=milkshark, createdTime=Thu May 19 07:41:00 CST 2016, time=2016-05-19, status=1, ipAttribution=)]
    2016-05-19 milkshark

    一家之言

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=138149, encodeId=037c13814994, content=拜读,好文, beContent=null, objectType=article, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzdAIB7UwTkHt6fQkBP8ictliaXtc5gCUmYdAW1sAETC2nhO3q6YjRHkUibyOCtP8ibmXNObTyd63A076/0, createdBy=d4111948983, createdName=1e10c84am36(暂无匿称), createdTime=Fri Sep 30 15:19:51 CST 2016, time=2016-09-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1307686, encodeId=71b6130e68617, content=<a href='/topic/show?id=85d2289e188' target=_blank style='color:#2F92EE;'>#免疫力#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=28971, encryptionId=85d2289e188, topicName=免疫力)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3547346, createdName=dongjia2010, createdTime=Fri May 20 00:50:00 CST 2016, time=2016-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1527609, encodeId=b1ef152e60914, content=<a href='/topic/show?id=68b5863e5d2' target=_blank style='color:#2F92EE;'>#自闭#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=86375, encryptionId=68b5863e5d2, topicName=自闭)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=159511872623, createdName=xiongke014, createdTime=Fri May 20 00:50:00 CST 2016, time=2016-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=86562, encodeId=ed5f865627b, content=一家之言, beContent=null, objectType=article, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7cde98330, createdName=milkshark, createdTime=Thu May 19 07:42:00 CST 2016, time=2016-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=86561, encodeId=7d4e865611f, content=这是真的?, beContent=null, objectType=article, channel=null, level=null, likeNumber=127, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7cde98330, createdName=milkshark, createdTime=Thu May 19 07:41:00 CST 2016, time=2016-05-19, status=1, ipAttribution=)]
    2016-05-19 milkshark

    这是真的?

    0

相关资讯

PNAS颠覆性观点:解决著名癌症悖论

人们普遍认为癌症是由突变积累引起的,科罗拉多大学的研究人员对此提出了挑战。他们在美国国家科学院院刊PNAS杂志上发表文章指出,人体组织相当于一个生态系统,健康细胞是最适合健康组织的。衰老、吸烟和其他压力因素会改变这一生态系统,让携带致癌突变的细胞获得生存优势。这一理论将对癌症治疗和药物开发产生深远的影响。 “我们一直在尝试用药物靶标癌细胞突变。但如果是机体生态系统在推动癌症生长,我们就应当优先想

2016年癌症领域12项颠覆性创新技术,细胞免疫治疗居首

美国联盟医疗体系在其举办的第二届世界医学创新峰会(World Medical Innovation Forum)中公布了由哈佛医学院专家选出的12项“颠覆性”的创新癌症诊断和治疗技术,有可能在10年内为癌症治疗带来革命性的改变。1. 细胞免疫治疗嵌合抗原受体(CAR)可以让T细胞靶向识别特定的肿瘤细胞。尽管该领域的开发仍处于早期,但许多癌症患者在其他方法都没有效果之后,对这种嵌合抗原受体T细胞

刘谦:传统医疗行业也能够拥抱移动医疗

经过长时间的计划和筹备,由梅斯医学发起的2015移动医疗创新大赛正在如火如荼地展开中,主办方每天都会接到大量来自全国甚至国外等参赛选手的咨询,火热程度可见一斑。作为大赛亮点之一,受到关注的评审团们也开始加入答疑解惑团队。此次接受采访的为医药作家,资深医药营销人士,移动医疗分析师刘谦。 想和移动医疗风口上的专家们面对面吗?快点来这里吧:2015梅斯医学移动医疗创新大赛

大数据可能不是颠覆医疗,而是颠覆医生,对医生提出更高要求

如果一个医生还在抱怨病人得了“搜索病”(指看病前习惯先上网查查自己可能得了什么病),那么这个医生大概已经落伍了。基于大数据在医疗领域的深度应用,美国斯坦福大学医学院一群富有创新精神的医学专家正和硅谷的医疗产业专家合作,推进一个最新的科研项目——“和你一样的病人”,通过这个智能系统,病人有望自查疾病,这也减少了医生因经验累积有限而导致的误诊或漏诊。这个系统有望成为医生的好帮手,也可能颠覆现有的医疗模

颠覆传统医疗模式,微医集团领衔全国首家互联网医院,落户乌镇

伴随“十三五”规划建议落地,健康中国正式升级至“国家战略”,以三医联动、医药分开、分级诊疗为核心的健康中国建设将成为“十三五”期间深化医疗卫生体制改革的重头戏。而“互联网+”将成为深化医改,推进健康中国建设的重要技术手段。 为缓解“看病难、看病贵”问题,党中央、国务院均在重要会议和文件中明确提出了构建分级诊疗就医格局和发挥互联网在医疗改革中的作用。习总书记2015年4月1日在中央深改领导小组举行

Baidu
map
Baidu
map
Baidu
map